H, S., T, R., R, A., D, N., & G, M. (2026). Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines. Journal of child and adolescent psychopharmacology, 36(1), 29. https://doi.org/10.1177/10445463251404404
Chicago Style (17th ed.) CitationH, Sadeh, Razi T, Arbel R, Netzer D, and Meiri G. "Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines." Journal of Child and Adolescent Psychopharmacology 36, no. 1 (2026): 29. https://doi.org/10.1177/10445463251404404.
MLA (9th ed.) CitationH, Sadeh, et al. "Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines." Journal of Child and Adolescent Psychopharmacology, vol. 36, no. 1, 2026, p. 29, https://doi.org/10.1177/10445463251404404.